| Biologic Therapy |
1 |
1 |
| Biosimilars |
0 |
0.99 |
| Sepsis |
0 |
0.53 |
| Arthritis |
0 |
0.49 |
| Psoriatic Arthritis |
0 |
0.49 |
| Rheumatoid Arthritis |
0 |
0.49 |
| Juvenile Rheumatoid Arthritis (JRA) |
0 |
0.47 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.46 |
| Tuberculosis |
0 |
0.42 |
| Otolaryngology |
0 |
0.41 |
| Fungal Infection |
0 |
0.38 |
| Crohn Disease |
0 |
0.24 |
| Psoriasis |
0 |
0.24 |
| Upper Respiratory Tract Infection |
0 |
0.23 |
| Patient Safety |
0 |
0.22 |
| Ulcerative Colitis |
0 |
0.2 |
| Adverse Effects |
0 |
0.16 |
| Ankylosing Spondylitis |
0 |
0.16 |
| Bacterial Sepsis |
0 |
0.16 |
| Child |
0 |
0.16 |
| Colitis |
0 |
0.16 |
| Histoplasmosis |
0 |
0.16 |
| Pharmacokinetics |
0 |
0.16 |
| Plaque Psoriasis |
0 |
0.16 |
| Respiratory Tract Infections |
0 |
0.16 |
| Sinusitis |
0 |
0.16 |
| Tumor |
0 |
0.16 |
| Headache |
0 |
0.14 |
| Inflammatory Bowel Disease |
0 |
0.14 |
| Vaccines |
0 |
0.14 |